Navigation Links
Union Links Resurrection Rating Downgrades to Poor Management
Date:5/30/2008

Moody's, Standard and Poor's and Fitch Ratings all take action; outlook negative

CHICAGO, May 30 /PRNewswire-USNewswire/ -- On May 27 and May 28, two major bond rating agencies, Fitch Ratings and Standard and Poor's, respectively, downgraded the debt of Resurrection Health Care citing declining patient census, consistently poor operating performance and management/governance shortcomings.

Fitch Ratings downgraded from 'A' to 'A-' the ratings on Resurrection Health Care's $643.5 million of outstanding bonds and reaffirmed its negative outlook for the company. Fitch cited the weak management/governance practices of the company as a factor in the downgrading.

"Resurrection Health Care's continued decline in the bond market is indicative of a managerial failure to develop a positive vision and program for the system's future," said Henry Bayer, executive director of the American Federation of State, County and Municipal Employees (AFSCME) Council 31. AFSCME is working with Resurrection employees who are seeking to form a union.

"One of the most glaring examples of Resurrection's insular management style is its uncompromising refusal to engage in any form of dialogue with its employees who are seeking a greater voice in the decisions affecting their working lives," Bayer said.

Standard and Poor's said its downgrade "reflects continued sizeable operating losses at Westlake and West Suburban hospitals, which began in 2007, and overall system volume declines -- both of which have resulted in significant system losses, including excess losses, that are much greater than budget through the first nine months of interim 2008."

On April 1, 2008 Moody's Investors Service placed Resurrection on its Watchlist for possible downgrade. Moody's stated that RHC "is reporting declining utilization measures across inpatient and outpatient services at each of its acute care facilities."

Fitch Ratings also cited the decline of inpatien
'/>"/>

SOURCE HEART/AFSCME
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Susan G. Komen for the Cure(R)s Circle of Promise Welcomes Gabrielle Union, Lalah Hathaway, Synthia SAINT JAMES as National Ambassadors
2. Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year
3. Senior Citizens, Unions, Physicians and Nurses Groups Lend Support to Hospitals State House Rally
4. Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
5. Kidney Care Community Applauds National Taxpayers Unions Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal Common Sense Coverage Reform
6. Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria
7. SEIU Seeks Damages for CNAs Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics
8. NLRB Orders New Union Election at OConnor Woods
9. Court Orders Service Union and Its President Andy Stern: Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn/NNOC
10. RNs Call on Service Employees Union (SEIU) President Stern to Renounce Violence Following Brutal Attack on Labor Event
11. CNA/NNOC: RNs Condemn Violent Service Union Attack at Michigan Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...gist explains prevalence of winter diaper rash and...sh season , COLLEGEVILLE, Pa., Dec. 2 /PRNewsw...per-clad babies, the winter months can mean cute l...nd not-so-cute and oh-so-painful little red bottom... until sunscreen season comes around again. , ...
(Date:12/2/2008)...alif., Dec. 2 The natio...oday to President-elect Obama urging him to fulfil...le and available by allowing any American to join ...a that a proposal pushed by health insurance compa...h insurance policies "amounts only to a government...
(Date:12/2/2008)...dy finds natural, less expensive treatments are ef... , PRINCETON, N.J., Dec. 2 Wi...oliday season is, for most, anticipated with excit... who suffer from Irritable Bowel Syndrome (IBS), t... embarrassing and debilitating gastrointestinal at...
(Date:12/2/2008)...nts treated with radiation prior to surgery for ad...r recurrence and better overall survival rates, ac...rt examined a treatment called neoadjuvant therapy...he spread of cancer, before surgery to remove the ...y and/or radiation. , Neoadjuvant therapy shoul...
Breaking Medicine News(10 mins):Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 2Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 3Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 4Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 2Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 3Health News:Holiday Season Brings New Hope to Millions Who Suffer from Common Chronic Health Disorder 2
...00 personnel of the Central Reserve Police Force (...en found to be addicted to drugs and alcohol// , a...the survey to find out the number of men who have ...ound 426 alcohol and drug addicts," said a senior ...
...esearchers have discovered that fatty acid ethyl e...iably portray the extent of fetal alcohol exposure...e if an infant has been exposed to alcohol during ...trictly associated with alcohol use," said Enrique...
...e sector YES Bank has signed an MoU with a leading... up a 75-100 million dollar health care fund cater...hs. // The Netherlands-based equity house will ru...ank would be the advisor. This would be its first ...
...ing to a new study, men with prostate cancer are m...ional changes, which prevents them //from trustin...isconceptions on the disease management options an...f others with prostate cancer to their own conditi...
Other Medicine News:Health News:Misconception on Treatment Options among Prostate Cancer Patients 2
(Date:12/2/2008)...PRNewswire/ -- Horizon Therapeutics, Inc., a,priv...ced that two pivotal,Phase 3 trials evaluating it...,met all primary endpoints. HZT-501, a novel, pro...g ibuprofen and famotidine, demonstrated a,statis...non-steroidal,anti-inflammatory drug (NSAID)-indu...
(Date:12/1/2008)...AGO, Dec. 2 A study has... new technique for imaging the breast, is not affe...l status, two factors that limit the effectiveness...er. Results will be presented today at the annual ...ca (RSNA). , , "The ability of PEM to dete...
(Date:12/1/2008)...ewswire/ -- S*BIO Pte Ltd today announced the init...potent and orally-active JAK2 inhibitor, in leadin...hronic idiopathic myelofibrosis (CIMF). , , ... tolerability of SB1518 in patients with CIMF and ... 1 part of the study will assess the safety profil...
(Date:12/1/2008)...he Prox1 gene is a two-way switch that, if turned ...ogrammed so that they lose their identity and beco...MPHIS, Tenn., Dec. 1 S... have discovered that a certain differentiated cel...requires the constant expression of a gene called ...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 1Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 2BioSpecifics Technologies Corp Announces Sale of Stock in Private Placement Offering 2587 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 2Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 3Rwandas Gishwati Forest selected as site for historic conservation project 1899 1Rwandas Gishwati Forest selected as site for historic conservation project 1899 2Rwandas Gishwati Forest selected as site for historic conservation project 1899 3
...RE)--Apr 19, 2007 - Amgen,(NASDAQ: AMGN) today ann...d, double-blind, placebo-controlled, multicenter P...00 previously untreated,patients with extensive-st...um-containing chemotherapy. The study demonstrated...f death (overall,survival Aranesp compared to plac...
...Apr 18, 2007 - Critical,Therapeutics, Inc. (Nasdaq...rch demonstrating a role in chronic inflammatory,a...otein (HMGB1), a,pro-inflammatory mediator and nuc... May 2007 issue of Nature Immunology. The,publicat...es that,can stimulate immune cells to produce pote...
Other Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
...clear, all-silicone Foley catheters eliminate pati... designs. As an inert, toxin-free elastomer, silic... catheter. Unlike silicone-coated latex Foleys, Ro...leach chemicals or water-soluble proteins that can...
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits the basket to expand the ureter more readily than standard flat-wire designs. The Unidex handle facilitate
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits greater radial dilation in the ureter. The Unidex handle facilitates easy, ergonomic one-handed operation.
Used to establish and maintain nephrostomy drainage following pyeloplasty. The open ureteral segment promotes patency and allows the stent to adjust as edema subsides. Supplied sterile in peel-open p
Medicine Products: